Bryan Johnson: I Just Took the Most Powerful Dose of DMT in the World... Here's What It Was Like

Brian Johnson's 5-MeO-DMT Experience

• Johnson ingested 9 mg intramuscularly and 18 mg via vaporization, resulting in an immediate onset (within 10 seconds) and a duration of approximately 48 hours prior to the interview.
• He describes the experience as an encounter with "raw consciousness and raw intelligence," noting it was significantly more intense than DMT (5–10x) and fundamentally non-visual compared to other psychedelics.
• The experience required total ego dissolution; Johnson states that resisting the "gates of hell" sensation leads to panic, while surrendering results in "unimaginable bliss and euphoria."
• Subjectively, Johnson characterizes the 5-MeO-DMT session as the "most dynamic experience" of his life, surpassing major life events like marriage or childbirth.

Neurological and Biological Mechanisms

• 5-MeO-DMT completely annihilates the Default Mode Network (DMN), the brain region responsible for self-referential rumination and ego construction.
• This "scrambling" of neural traffic patterns is intended to drive neuroplasticity, allowing the brain to form new connections and dissolve rigid thought patterns associated with aging and trauma.
• Johnson observed a "metabolic reset" post-5-MeO-DMT, evidenced by a shift in blood glucose levels from the top 99.5th percentile to the top 99.9th percentile.
• Functional MRI (fMRI) and EEG data collected via Kernel and other modalities show a restoration of youthful brain connectivity patterns, comparable to the effects seen in prior psilocybin trials but more profound.
• Post-experience behavioral changes include a return to "childlike" laughter in dreams and a cessation of adult-style relationship conflict resolution (i.e., holding grudges or weaponizing past grievances).

Longevity and Future Protocols

• Johnson views psychedelics not merely as therapeutic for mental health but as critical interventions for "anti-aging" and psychological rejuvenation, specifically to maintain a "can-do" disposition in a rapidly changing world dominated by AI.
• He plans to implement a personalized mitochondrial rejuvenation therapy by extracting mitochondria from a young family member (maternal line match) via a third-party bioreactor to replace his own degrading mitochondria.
• Johnson is establishing "organoids" using his own induced pluripotent stem cells (iPSCs) to simulate drug effects on a "Brian Johnson heart, liver, and lungs" in vitro before human testing.
• He is actively pursuing replication of a FoxO3 gene therapy study (involving mesenchymal stem cells) that showed over 50% tissue rejuvenation in previous trials.
• Johnson is an investor in New Limit, a company using computational methods to solve the discovery and dosing challenges of Yamanaka factors for cellular reprogramming.

Risk Assessment and Philosophical Implications

• Johnson acknowledges the non-zero risk of psychosis or permanent negative changes but attributes most adverse events to unquantified doses and poor "set and setting" rather than the substance itself.
• He argues that the current legal and social stigma prevents the rigorous, supervised application necessary to mitigate risks and maximize longevity benefits.
• The experience raises philosophical questions regarding personal identity; Johnson accepts that his post-psychedelic self is a "reconstructed" version of his previous self, with shifted values but unchanged parental responsibilities.
• He notes that investors have previously included clauses in deal documents prohibiting founders from using psychedelics due to fears of dramatic life changes, yet Johnson reports no desire to abandon his work or family following the 5-MeO-DMT experience.
• Johnson predicts that a suite of longevity interventions (GLP-1s, then gene/cell therapies) will shift humanity's view of lifespan from a sci-fi pursuit for the wealthy to a foundational element of societal abundance.

Forward-Looking Statements

• Johnson posits that psychedelics will serve as a unique tool for "psycho-flexibility," enabling humans to adapt their cognitive wiring to keep pace with the speed of AI-driven innovation.
• He intends to continue quantifying the decay curve of 5-MeO-DMT effects to determine if the psychological "reset" is permanent or requires periodic reinforcement.
• Future plans include rigorous testing of mitochondrial transplantation and FoxO3 plasmid therapies to address specific tissue regeneration needs that psychedelics may not reach.
• Johnson asserts that improving human biological health and abundance is a prerequisite for reducing global internal conflict and societal malaise.